These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 22087017

  • 1. Pharmacodynamic responses of plasma and tissue C-type natriuretic peptide to GH: correlation with linear growth in GH-deficient rats.
    Prickett TC, Bothwell JC, Yandle TG, Richards AM, Espiner EA.
    J Endocrinol; 2012 Feb; 212(2):217-25. PubMed ID: 22087017
    [Abstract] [Full Text] [Related]

  • 2. Skeletal contributions to plasma CNP forms: evidence from regional sampling in growing lambs.
    Prickett TC, Charles CJ, Yandle TG, Richards AM, Espiner EA.
    Peptides; 2009 Dec; 30(12):2343-7. PubMed ID: 19664666
    [Abstract] [Full Text] [Related]

  • 3. Effect of sex steroids on plasma C-type natriuretic peptide forms: stimulation by oestradiol in lambs and adult sheep.
    Prickett TC, Barrell GK, Wellby M, Yandle TG, Richards AM, Espiner EA.
    J Endocrinol; 2008 Dec; 199(3):481-7. PubMed ID: 18784186
    [Abstract] [Full Text] [Related]

  • 4. Effect of nutrition on plasma C-type natriuretic peptide forms in adult sheep: evidence for enhanced C-type natriuretic peptide degradation during caloric restriction.
    Prickett TC, Ryan JF, Wellby M, Barrell GK, Yandle TG, Richards AM, Espiner EA.
    Metabolism; 2010 Jun; 59(6):796-801. PubMed ID: 20005543
    [Abstract] [Full Text] [Related]

  • 5. C-type Natriuretic Peptide: a novel biomarker of steroid induced bone toxicity in children with acute lymphoblastic leukemia (ALL).
    Prickett TC, Lyver A, Wilson R, Espiner EA, Sullivan MJ.
    Peptides; 2012 Jul; 36(1):54-9. PubMed ID: 22564489
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth.
    Prickett TC, Lynn AM, Barrell GK, Darlow BA, Cameron VA, Espiner EA, Richards AM, Yandle TG.
    Pediatr Res; 2005 Aug; 58(2):334-40. PubMed ID: 16006435
    [Abstract] [Full Text] [Related]

  • 8. Dynamic response of C-type natriuretic peptide and its aminoterminal propeptide (NTproCNP) to growth hormone treatment in children with short stature.
    Olney RC, Salehi P, Prickett TC, Lima JJ, Espiner EA, Sikes KM, Geffner ME.
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):561-8. PubMed ID: 27177682
    [Abstract] [Full Text] [Related]

  • 9. Plasma amino-terminal pro C-type natriuretic Peptide in the neonate: relation to gestational age and postnatal linear growth.
    Prickett TC, Dixon B, Frampton C, Yandle TG, Richards AM, Espiner EA, Darlow BA.
    J Clin Endocrinol Metab; 2008 Jan; 93(1):225-32. PubMed ID: 17971429
    [Abstract] [Full Text] [Related]

  • 10. C-type natriuretic peptide forms in adult hyperthyroidism: correlation with thyroid hormones and markers of bone turnover.
    Schouten BJ, Prickett TC, Hunt PJ, Richards AM, Geffner ME, Olney RC, Espiner EA.
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):790-6. PubMed ID: 22103885
    [Abstract] [Full Text] [Related]

  • 11. Response of plasma CNP forms to acute anabolic and catabolic interventions in growing lambs.
    Prickett TC, Barrell GK, Wellby M, Yandle TG, Richards AM, Espiner EA.
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1395-400. PubMed ID: 17227962
    [Abstract] [Full Text] [Related]

  • 12. Amino-terminal propeptide of C-type natriuretic peptide and linear growth in children: effects of puberty, testosterone, and growth hormone.
    Olney RC, Prickett TC, Yandle TG, Espiner EA, Han JC, Mauras N.
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4294-8. PubMed ID: 17684048
    [Abstract] [Full Text] [Related]

  • 13. C-type natriuretic peptide in prostate cancer.
    Nielsen SJ, Iversen P, Rehfeld JF, Jensen HL, Goetze JP.
    APMIS; 2009 Jan; 117(1):60-7. PubMed ID: 19161538
    [Abstract] [Full Text] [Related]

  • 14. Is GH therapy useful to preserve bone mass in transition-phase patients with GH deficiency?
    Aimaretti G, Corneli G, Rovere S, Croce CG, Ghigo E, Procopio M.
    J Endocrinol Invest; 2005 Jan; 28(10 Suppl):28-32. PubMed ID: 16550719
    [Abstract] [Full Text] [Related]

  • 15. C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.
    Olney RC, Prickett TC, Espiner EA, Mackenzie WG, Duker AL, Ditro C, Zabel B, Hasegawa T, Kitoh H, Aylsworth AS, Bober MB.
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E355-9. PubMed ID: 25387261
    [Abstract] [Full Text] [Related]

  • 16. Alterations of growth plate and abnormal insulin-like growth factor I metabolism in growth-retarded hypokalemic rats: effect of growth hormone treatment.
    Gil-Peña H, Garcia-Lopez E, Alvarez-Garcia O, Loredo V, Carbajo-Perez E, Ordoñez FA, Rodriguez-Suarez J, Santos F.
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F639-45. PubMed ID: 19587145
    [Abstract] [Full Text] [Related]

  • 17. Regional sampling and the effects of experimental heart failure in sheep: differential responses in A, B and C-type natriuretic peptides.
    Charles CJ, Prickett TC, Espiner EA, Rademaker MT, Richards AM, Yandle TG.
    Peptides; 2006 Jan; 27(1):62-8. PubMed ID: 16095755
    [Abstract] [Full Text] [Related]

  • 18. Combined treatment with GH and IGF-I: additive effect on cortical bone mass but not on linear bone growth in female rats.
    Sundström K, Cedervall T, Ohlsson C, Camacho-Hübner C, Sävendahl L.
    Endocrinology; 2014 Dec; 155(12):4798-807. PubMed ID: 25243853
    [Abstract] [Full Text] [Related]

  • 19. Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice.
    Kake T, Kitamura H, Adachi Y, Yoshioka T, Watanabe T, Matsushita H, Fujii T, Kondo E, Tachibe T, Kawase Y, Jishage K, Yasoda A, Mukoyama M, Nakao K.
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1339-48. PubMed ID: 19808910
    [Abstract] [Full Text] [Related]

  • 20. Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism.
    Sanchez CP, He YZ.
    J Am Soc Nephrol; 2005 Apr; 16(4):929-38. PubMed ID: 15728789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.